Clinical Trial Update: Effects of Allogenic Umbilical Cord-Derived Mesenchymal Stem Cells on Patients with Rotator Cuff Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating allogeneic umbilical cord-derived mesenchymal stem cells in patients with rotator cuff disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotator Cuff Disease

Drugs mentioned

• Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Rotator Cuff Disease | Phase 1, Phase 2 | Status: RECRUITING